R87.61 Категория · требуется уточнение Abnormal cytological findings in specimens from cervix uteri

ICD-10-CM R87.61 identifies “Abnormal cytological findings in specimens from cervix uteri” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Глава 18: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Инструкции к коду

Excludes 18
  • abnormal cytological findings in specimens from other female genital organs (R87.69)
  • abnormal cytological findings in specimens from vagina (R87.62-)
  • carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
  • cervical intraepithelial neoplasia I [CIN I] (N87.0)
  • cervical intraepithelial neoplasia II [CIN II] (N87.1)
  • cervical intraepithelial neoplasia III [CIN III] (D06.-)
  • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
  • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
Excludes 22
  • cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
  • cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Инструкции вышестоящих уровней

Главы 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 24
  • abnormal findings on antenatal screening of mother (O28.-)
  • certain conditions originating in the perinatal period (P04-P96)
  • signs and symptoms classified in the body system chapters
  • signs and symptoms of breast (N63, N64.5)
Note9
  • This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
  • Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
  • The conditions and signs or symptoms included in categories R00-R94 consist of:
  • (a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
  • (b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
  • (c) provisional diagnosis in a patient who failed to return for further investigation or care;
  • (d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
  • (e) cases in which a more precise diagnosis was not available for any other reason;
  • (f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 12
  • abnormal findings on antenatal screening of mother (O28.-)
  • diagnostic abnormal findings classified elsewhere - see Alphabetical Index
Excludes 23
  • abnormal findings on examination of blood, without diagnosis (R70-R79)
  • abnormal findings on examination of urine, without diagnosis (R80-R82)
  • abnormal tumor markers (R97.-)

R87 · Abnormal findings in specimens from female genital organs

Includes3
  • abnormal findings in secretion and smears from cervix uteri
  • abnormal findings in secretion and smears from vagina
  • abnormal findings in secretion and smears from vulva

Более конкретные коды

Ссылки в официальном указателе
Ссылки из других кодов (2)
История

История кода

Нет изменений с первого наблюдения

ИзменёнБез изменений
FY2016

Действует с

  • Первое наблюдение

Abnormal cytological findings in specimens from cervix uteri

Категория — выберите более точный код

CDC/NCHS · FY2016

Все версии (19)

Все версииДействует сИстория кода
FY20162015-10-01Первое наблюдение
FY20172016-10-01Без изменений в таблице
FY20182017-10-01Без изменений в таблице
FY20192018-10-01Без изменений в таблице
FY20202019-10-01Без изменений в таблице
FY2020 · April2020-04-01Без изменений в таблице
FY20212020-10-01Без изменений в таблице
FY2021 · 01-012021-01-01Без изменений в таблице
FY20222021-10-01Без изменений в таблице
FY2022 · 04-012022-04-01Без изменений в таблице
FY20232022-10-01Без изменений в таблице
FY2023 · 04-012023-04-01Без изменений в таблице
FY20242023-10-01Без изменений в таблице
FY2024 · 04-012024-04-01Без изменений в таблице
FY20252024-10-01Без изменений в таблице
FY2025 · 04-012025-04-01Без изменений в таблице
FY20262025-10-01Без изменений в таблице
FY2026 · April2026-04-01Без изменений в таблице
FY20272026-10-01Без изменений в таблице

Изучите более конкретные коды этой категории. Проверка по справочнику не подтверждает клиническую обоснованность и не гарантирует возмещение.